| Rachel Wolfe, | |
|
1604 Burtner Rd, Ste 2300, Natrona Heights, PA 15065-2845 | |
| (724) 226-1400 | |
| Not Available |
| Full Name | Rachel Wolfe |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 1604 Burtner Rd, Natrona Heights, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952622144 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD449567 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc St Margaret | Pittsburgh, PA | Hospital |
| Allegheny Valley Hospital | Natrona, PA | Hospital |
| Magee Womens Hospital Of Upmc Health System | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upmc Community Medicine Inc | 2062318975 | 690 |
News Archive
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
Despite the advent of a new generation of stents, patients with multiple narrowed arteries in the heart who received coronary artery bypass grafting fared better than those whose arteries were opened with balloon angioplasty and stents in a study presented at the American College of Cardiology's 64th Annual Scientific Session.
Blood pressure variability over the long term predicts mortality among patients receiving treatment for hypertension, a study shows.
Local health departments in Northern Virginia, the District of Columbia and Maryland are investigating an outbreak of serious skin reactions among at least 16 women who have developed the condition after receiving cosmetic injections in October and November 2004.
Three HMOs that administer managed care plans for Connecticut's Medicaid program must make public the rates they pay providers and other information, state Superior Court Judge George Levine ruled on Wednesday, the Hartford Courant reports.
› Verified 2 days ago
| Entity Name | Upmc Community Medicine Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558976092 PECOS PAC ID: 2062318975 Enrollment ID: O20040217000388 |
News Archive
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
Despite the advent of a new generation of stents, patients with multiple narrowed arteries in the heart who received coronary artery bypass grafting fared better than those whose arteries were opened with balloon angioplasty and stents in a study presented at the American College of Cardiology's 64th Annual Scientific Session.
Blood pressure variability over the long term predicts mortality among patients receiving treatment for hypertension, a study shows.
Local health departments in Northern Virginia, the District of Columbia and Maryland are investigating an outbreak of serious skin reactions among at least 16 women who have developed the condition after receiving cosmetic injections in October and November 2004.
Three HMOs that administer managed care plans for Connecticut's Medicaid program must make public the rates they pay providers and other information, state Superior Court Judge George Levine ruled on Wednesday, the Hartford Courant reports.
› Verified 2 days ago
| Entity Name | Renaissance Family Practice-upmc, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467616813 PECOS PAC ID: 7012085558 Enrollment ID: O20081010000052 |
News Archive
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
Despite the advent of a new generation of stents, patients with multiple narrowed arteries in the heart who received coronary artery bypass grafting fared better than those whose arteries were opened with balloon angioplasty and stents in a study presented at the American College of Cardiology's 64th Annual Scientific Session.
Blood pressure variability over the long term predicts mortality among patients receiving treatment for hypertension, a study shows.
Local health departments in Northern Virginia, the District of Columbia and Maryland are investigating an outbreak of serious skin reactions among at least 16 women who have developed the condition after receiving cosmetic injections in October and November 2004.
Three HMOs that administer managed care plans for Connecticut's Medicaid program must make public the rates they pay providers and other information, state Superior Court Judge George Levine ruled on Wednesday, the Hartford Courant reports.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Wolfe, 1604 Burtner Rd, Ste 2300, Natrona Heights, PA 15065-2845 Ph: () - | Rachel Wolfe, 1604 Burtner Rd, Ste 2300, Natrona Heights, PA 15065-2845 Ph: (724) 226-1400 |
News Archive
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
Despite the advent of a new generation of stents, patients with multiple narrowed arteries in the heart who received coronary artery bypass grafting fared better than those whose arteries were opened with balloon angioplasty and stents in a study presented at the American College of Cardiology's 64th Annual Scientific Session.
Blood pressure variability over the long term predicts mortality among patients receiving treatment for hypertension, a study shows.
Local health departments in Northern Virginia, the District of Columbia and Maryland are investigating an outbreak of serious skin reactions among at least 16 women who have developed the condition after receiving cosmetic injections in October and November 2004.
Three HMOs that administer managed care plans for Connecticut's Medicaid program must make public the rates they pay providers and other information, state Superior Court Judge George Levine ruled on Wednesday, the Hartford Courant reports.
› Verified 2 days ago
Matthew Vasil, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1604 Burtner Rd Ste 2300, Natrona Heights, PA 15065 Phone: 724-226-1400 | |
Elaine B Scott, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1301 Carlisle St, Natrona Heights, PA 15065 Phone: 724-226-7330 Fax: 724-226-7150 | |
Jeffrey Lineman, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1604 Burtner Rd Ste 2300, Suite 2300, Natrona Heights, PA 15065 Phone: 724-226-1400 | |
Benjamin Carnahan, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1604 Burtner Rd Ste 2300, Natrona Heights, PA 15065 Phone: 724-226-1400 | |
Dr. Vincent Bolisay Vargas, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1719 Union Ave Ste A, Natrona Heights, PA 15065 Phone: 724-226-2128 Fax: 724-226-2498 | |
Dr. Kaleigh Spencer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1604 Burtner Rd Ste 2300, Natrona Heights, PA 15065 Phone: 724-226-1400 | |
Luke Jesser, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1604 Burtner Rd Ste 2300, Suite 2300, Natrona Heights, PA 15065 Phone: 724-226-1400 |